PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD
A. Munoz Montiel (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), P. Ruiz-Esteban (Málaga, Spain), J. Rioja Villodres (Málaga, Spain), M. Prunera Pardell (Málaga, Spain), M. Sanchez Chaparro (Málaga, Spain), N. García Casares (Málaga, Spain), P. Valdivielso Felices (Málaga, Spain), A. Doménech Del Río (Málaga, Spain)
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Munoz Montiel (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), P. Ruiz-Esteban (Málaga, Spain), J. Rioja Villodres (Málaga, Spain), M. Prunera Pardell (Málaga, Spain), M. Sanchez Chaparro (Málaga, Spain), N. García Casares (Málaga, Spain), P. Valdivielso Felices (Málaga, Spain), A. Doménech Del Río (Málaga, Spain). PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD. 657
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: